Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Novavax Announces Its First-in-Human Coronavirus Vaccine Trial Will Begin in Mid-May

Shares of Novavax traded 20% higher setting a new 52-week high price after the company reported that it has accelerated initiation of a Phase 1 clinical trial for its coronavirus vaccine candidate NVX-CoV2373. The study will commence in mid-May with preliminary results expec...
Streetwise Reports | April 9, 2020 |

Repeating Patterns In Human Behavior

GREED AND FEAR The January 1987 edition of Military Review, a professional journal of the U.S. Army, noted: “Since the mind of the individual soldier has not changed and fear is the crucial factor in the outcome of all battles, tactics must be directed not just against...
Chris Ciovacco | December 23, 2019 |

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson | July 2, 2024 |

Could DehydraTECH CBD be Worth $3 Billion a Year to Lexaria?

PCG Digital -- Hypertension, or high blood pressure as it's commonly known, affects over three million Americans every year and is a primary or contributing cause of death for 25% of them. On a global scale, hypertension kills roughly 7.6 milli on people per year . L...
Featured Submission | March 9, 2021 |

Flying Under the Radar with a Possible COVID-19 Treatment

Investors would think a pharmaceutical company heading into Phase 2b/3 human trials for treating the third most malignant disease after lung cancer and pancreatic cancer would draw eyes from major players. If that same company announced it was embarking on Phase2b/3 human tri...
Stockhouse Editorial | September 8, 2020 |

Nov 23rd 2019, Crypto Chartbook – Why markets work

Why markets work We as humans are fooled by a brain that functions on comparison. However, based on the true principle, every moment is unique and we expand with every time increment into an absolutely new future (big bang theory). We would be overwhelmed by the vastness o...
Korbinian Koller | November 26, 2019 |

Aurora, Bayer, XPhyto - scalable growth markets with potential

Health is the most precious good in the life of a human being. The preservation and improvement of the quality of life is a large business area. Investors around the globe have the opportunity to participate in many different areas of research and development of products and t...
Mario Hose | June 8, 2020 |

Gazprom, Saturn Oil & Gas, Shell - Winners of a supply chain law

In recent weeks, the German media have frequently reported on a so-called supply chain law. The aim of such a law is to ensure that German companies respect human rights and protect the environment in the procurement of materials and products. The world should become a bette...
Mario Hose | July 21, 2020 |

BP, Saturn Oil & Gas, Shell - why this share is now interesting

The Corona pandemic is still keeping politics and business busy. The restrictions in everyday life are causing many changes for people. An end to the situation is not yet in sight and therefore great hope is being placed in the development of a vaccine against Covid-19. Those ...
Mario Hose | August 21, 2020 |

The promise of AI

In ‘The Terminator’ series of action films starring Arnold Schwarzenegger, a cybernetic organism (cyborg) is programmed from the future to go back in time and kill the mother of the scientist who leads the fight against Skynet, an artificial intelligence syst...
Richard (Rick) Mills | November 22, 2019 |
1 2 3 4 5 6 7 8 9 10 ...